Categories
Health

‘It’s Powerful to Get Out’: How Caribbean Medical Colleges Fail Their College students

Last summer, when Dr. Sneha Sheth went online to begin filling out applications for residency — the next stage of her training after medical school — she was hit with a jolt of disappointment.

Of the 500 residency programs she was considering, nearly half had been labeled unfriendly to international medical students, like her, by the website Match a Resident, which helps medical students abroad navigate the U.S. residency application process. Dr. Sheth submitted her applications in September and spent months on edge. Then came the distress of rejections from numerous programs, and no responses from others.

“There are 50 percent of programs that don’t want you, which is a scary feeling,” said Dr. Sheth, 28, who graduated recently from a Caribbean medical school. “It’s like, if they don’t want you, who will?”

The frustrations of the match process, which assigns graduates to programs where they can begin practicing medicine, made Dr. Sheth question whether she had been foolish to enroll in a Caribbean medical school. She had spent tens of thousands of dollars but ended up shut out of American residency programs (although she recently landed a spot in a Canadian one).

In the 1970s, a wave of medical schools began to open across the Caribbean, catering largely to American students who had not been accepted to U.S. medical schools; today there are roughly 80 of them. Unlike their U.S. counterparts, the schools are predominantly for-profit institutions, their excess revenue from tuition and fees going to investors.

Admissions standards at Caribbean schools tend to be more lax than at schools in the United States. Many do not consider scores on the standardized Medical College Admission Test as a factor in admissions. Acceptance rates at some are 10 times as high as those at American schools. They also do not guarantee as clear a career path. The residency match rate for international medical graduates is about 60 percent, compared with over 94 percent for U.S. graduates.

In 2019, Tania Jenkins, a medical sociologist, studied the composition of U.S. residency programs and found that at more than a third of the country’s biggest university-affiliated internal medicine programs, the residency population was made up overwhelmingly of U.S. medical graduates. Caribbean medical school students match into residencies at a rate 30 percentage points lower than their U.S. counterparts.

“U.S. medical school graduates enjoy tailwinds,” Ms. Jenkins said. “Caribbean medical students experience headwinds. They have a number of obstacles they have to overcome in order to be given a chance at lower-prestige and lower-quality training institutions.”

The challenges that Caribbean medical students face in career advancement have raised questions about the quality of their education. But with the rapid rise in the number of medical schools worldwide — from around 1,700 in the year 2000 to roughly 3,500 today — tracking and reporting on the quality of medical schools abroad has proved a difficult task.

In recent years, medical educators and accreditors have made a more concerted effort to evaluate the credibility of those institutions, with the goal of keeping applicants informed about subpar Caribbean schools, which charge tens of thousands of dollars in tuition and fees and sometimes fail to position their students for career success.

That effort has largely been led by the Educational Commission for Foreign Medical Graduates, which reviews and provides credentials for graduates of foreign medical schools, including documentation of their exam scores and their academic histories. In 2010, the commission announced an initiative requiring every physician applying for certification to have graduated from an accredited medical school. The group also said it would more closely scrutinize the standards for organizations that accredit medical schools around the world. The new rule will take effect by 2024.

The commission has already penalized two Caribbean medical schools — the University of Science, Arts & Technology Faculty of Medicine in Montserrat and the Atlantic University School of Medicine in Antigua and Barbuda. The group refused to grant credentials to any of those schools’ graduates, saying it had found the schools to be “egregious in terms of how they treated students and misrepresented themselves.” The medical school in Montserrat subsequently sued the commission, but the case was dismissed in a U.S. federal court. The University of Science, Arts & Technology Faculty of Medicine in Montserrat did not respond to requests for comment.

“I’m very concerned about students’ being taken advantage of by schools that may not give them proper information as to how they’re going to learn and what their opportunities are going to be when they finish school,” said Dr. William Pinsky, head of the commission.

He said he hoped that students would be better protected by 2024, when accrediting organizations plan to complete evaluations of all international medical schools through a more rigorous accreditation process.

One of the primary accrediting bodies for Caribbean medical schools is the Caribbean Accreditation Authority for Education in Medicine and Other Health Professions, known as CAAM-HP. Lorna Parkins, executive director of the organization, said that some of the key factors the group considers in denying accreditation include high attrition rates and low exam pass rates.

Credit…via Yasien Eltigani

But Caribbean schools occasionally misrepresent their accreditation status on their websites, Ms. Parkins added. She sometimes hears from students who are struggling to transfer out of lower-quality schools.

“It’s my daily concern,” Ms. Parkins said. “I know students have very high loans, and their families make great sacrifices to educate them.”

Applying to medical school in the United States requires a certain level of know-how: how to study for the MCAT; how to apply for loans; and how to make yourself competitive for a select number of spots. Applicants with less access to resources and mentoring are at a disadvantage and are sometimes less aware of the drawbacks of international medical education.

Dr. Yasien Eltigani, 27, who is Sudanese and immigrated from the United Arab Emirates to the United States, said he had little assistance in navigating the obstacle course of medical school applications. He applied to only nine schools, all in Texas, not realizing that most U.S. students apply more widely, and was rejected from all of them. Two years later, when he saw a Facebook advertisement for St. George’s University in Grenada, he decided to apply.

Looking back, he says he wished he had reapplied to American schools instead of going the Caribbean route. Although he was able to match into a residency program, which he recently started, he found the process to be anxiety-inducing.

“If you fall behind in a U.S. medical school, your chances of matching are decent, whereas in a Caribbean medical school you’re at risk,” he said. “As an immigrant, I didn’t have much in the way of guidance.”

Caribbean medical school administrators say their intentions are straightforward: They aim to expand opportunities for students to go to medical school, especially those from racially, socioeconomically and geographically diverse backgrounds, to include people who might not have traditionally pursued careers in medicine.

“U.S. medical schools have more applicants than they know what to do with,” said Neil Simon, president of the American University of Antigua College of Medicine. “So why do they object to medical schools that have obtained approval and are educating a student population that is much more diverse? Wouldn’t you think they’d welcome us with open arms?”

Mr. Simon said that he was aware of the bias that A.U.A.’s graduates confront as they apply for residency positions in the United States and that he saw the stigma as unfounded. He added that international medical graduates were more likely to pursue family medicine and to work in underserved areas, especially rural communities.

But experts say that the proliferation of for-profit medical schools does not always serve the best interests of students. The Liaison Committee on Medical Education, which credentials U.S. schools, did not recognize any for-profit schools until 2013, when it changed its stance following an antitrust ruling mandating that the American Bar Association accredit for-profit law schools. Among medical educators, substantial skepticism still exists toward the for-profit model.

“If medical students are viewed as dollar signs rather than trainees that require lots of investment, support and guidance, that fundamentally changes the training experience of these students and the way their education pans out,” Ms. Jenkins said.

Some students at Caribbean medical schools said the quality of their education had declined even further in recent years as some campuses faced natural disasters.

In 2017 when Hurricane Maria hit Dominica, where Ross University School of Medicine’s campus was situated, the school decided to offer its students accommodations on a ship docked near St. Kitts. To some of the students, this sounded like an adventure. But as soon as they arrived on the boat, they realized that it did not lend itself to rigorous study.

With few study spots or electric outlets available on the ship, Kayla, a first-year-student, awoke each day at 2 a.m. to claim a place where she could study for the day. (Kayla asked to be identified by just her first name so that she could freely share her experience.) Her exams were held in a room filled with windows that looked out over the ocean waves. She and her classmates said that if they looked up from their tests, they had immediately felt nauseated. She couldn’t take Dramamine, she said, because that exacerbated her fatigue. Some of her classmates left before the semester ended because they could not handle study conditions on the ship.

“We understand that extenuating circumstances posed challenges for all,” a spokesman for Adtalem Global Education, the parent organization of Ross University School of Medicine, said in an email. “We took extraordinary measures to provide options for students to continue their studies or to take a leave of absence until campus facilities could be restored.”

But the combined challenges of these schools have given way to a saying: “It’s extremely easy to get into Caribbean schools,” said Dr. Abiola Ogunbiyi, a recent graduate of Trinity Medical Sciences University in Saint Vincent. “But it’s tough to get out.”

As accreditation standards evolve, Ms. Jenkins said one of the most critical ways to protect students was to ensure transparency from the schools. “People should go into their training with their eyes wide open,” she said.

Categories
World News

Iran’s Incoming President Vows Powerful Line on Missiles and Militias

Iran will not negotiate with the United States over its ballistic missile or regional militia programs, its Conservative-elect Ebrahim Raisi said on Monday.

In his first press conference as President-elect, Raisi said he would not meet with President Biden and urged the United States to uphold a 2015 agreement that restricted Iran’s nuclear program in return for lifting economic sanctions.

“My serious recommendation to the US government is to immediately return to its obligations to lift all sanctions and show their goodwill,” he said in a briefing with national and international reporters in Tehran on Monday.

“Regional issues and missiles are non-negotiable,” he said, adding that the United States had failed to enforce the issues it “negotiated, agreed and committed to”.

The comments come as the US and Iran negotiate through mediators in Vienna to revive the 2015 agreement. Mr Biden has pledged to seek a return to the deal, which would lift around 1,600 sanctions against Iran after the Trump administration stepped out of the deal in 2018, calling it too weak.

Mr Raisi’s promise to refuse to negotiate missile and militia issues falling outside of the 2015 nuclear deal came as no surprise, analysts said, reiterating the positions he had taken as a candidate as well as those of the current administration.

“It was to be expected – he knows more about what he will not do than about concrete foreign policy plans,” says Hamidreza Azizi, visiting scholar at the German Institute for International and Security Affairs in Berlin. “He just repeated the general positions of the Islamic Republic.”

When meeting with Mr Biden, the elected Iranian President had only one word answer: “No”.

What is striking is the determination with which Raisi declined the possibility of a meeting with the US president, said Azizi, attributing this to his lack of diplomatic background.

“The tone was not diplomatic and we will see that again during his presidency as he has no diplomatic experience,” he said.

Talal Atrissi, a sociologist at the Lebanese University in Beirut who studies Iran and its regional allies, said Raisi’s victory was a blow to reformists and would undermine Iran’s relations with its regional militias known as the “Axis of Resistance” , strengthen. These include Hezbollah in Lebanon, various militias in Syria and Iraq, and the Houthi rebels in Yemen, who are supported by Iran and who share their anti-Israel and anti-American stance.

“Raisi will remain committed to the Axis of Resistance,” said Atrissi, adding that Iran’s regional activities were never directed by the President, but by the Islamic Revolutionary Guard Corps.

“This relationship is not going to change at all,” he said. “On the contrary, there will be more cooperation.”

Trump’s “maximum pressure” campaign against Iran had failed, Raisi said on Monday, according to the Iranian state-controlled broadcaster Press TV.

A negotiating team involved in the indirect talks in Vienna will continue those talks until his government takes its place, he said. He added that he supported discussions that safeguard Iran’s national interests, but “we will not allow talks for talks’ sake”.

This appeal also extended to European nations, said Raisi, “who must not allow themselves to be influenced by US pressure and must meet their obligations.”

Raisi, an ultra-conservative chief justice believed to be the potential successor to the country’s top leader, Ayatollah Ali Khamenei, has been charged with human rights abuses, including participating in a mass execution of opponents of the government in 1988. That record has earned him sanctions from the United States .

However, on Monday he called himself a “defender of human rights and the safety and comfort of the people,” adding that he would continue this role as president.

He also voiced a new idea: Iran is ready to reestablish diplomatic ties with Saudi Arabia, which collapsed in 2016 after Iranians protested the kingdom’s execution of a prominent Shiite cleric that stormed Saudi diplomatic missions in Iran.

That proposal, Azizi said, appeared to be part of Iran’s efforts to develop bilateral ties with other countries in the region independently of the United States, including American allies like Saudi Arabia.

Also over the weekend, the Iranian nuclear power plant in Bushehr was temporarily shut down, with officials calling it a “technical fault” and telling Iranians that the shutdown, which began on Saturday, would take a few days, according to the media.

Farnaz Fassihi contributed to the coverage.

Categories
Health

Biogen faces robust questions on $56Okay-a-year worth of latest Alzheimer’s drug

A person skates past Biogen Inc. headquarters in Cambridge, Massachusetts on Monday, June 7, 2021.

Adam Glanzman | Bloomberg | Getty Images

Biogen faced tough questions from Wall Street analysts Tuesday about the annual cost of $ 56,000 for its newly approved Alzheimer’s drug Aduhelm – a price that executives call “fair” and “responsible”.

Biogen’s shares rose 38% Monday after the FDA announced it had approved the company’s drug scientifically known as aducanumab. It’s the first drug approved by U.S. regulators to slow cognitive decline in people with Alzheimer’s, and the first new drug for the disease in nearly two decades.

The biotech company said it is charging $ 56,000 for an annual course of the new treatment, more than the $ 10,000-25,000 price some Wall Street analysts expected. This is the wholesale price, and the cost that patients actually pay depends on their health insurance plan.

Some analysts and stakeholders immediately questioned how the company could justify the price – about five times higher than expected – especially as medical experts continue to debate whether there is enough evidence that the drug actually works and the industry has been criticized for drug prices .

The FDA departed from the advice of its independent panel of external experts, which unexpectedly declined to approve the drug last fall, citing inconclusive data.

“Our only concern here is the annual cost of aducanumab and whether the sticker shock at $ 56,000 a year (we were at $ 10,000) could further stimulate drug price reviews,” Stifel analyst Jeff Preis told investors Monday in a note.

On a call to investors Tuesday morning, Evercore ISI analyst Umer Raffat congratulated the Massachusetts-based company on US approval of the drug before asking executives to explain the price.

“I think there is a discrepancy between some of the words you shared in your press releases like responsibility, access, health equity, and price, especially given the basic care population,” he told executives.

JP Morgan analyst Cory Kasimov later asked executives how much the state health insurance program Medicare is likely to pay for the drug and how concerned executives are about the “backlash” the industry will face on pricing.

Biogen executives said the overall price of the new treatment is “underpinned” by the value it is expected to bring to patients, caregivers and society. They insisted that the price was “responsible” and stated that the disease costs the US billions each year.

The Alzheimer’s Association estimates that more than 6 million Americans are living with the disease. The company said it currently has the capacity to deliver the drug to 1 million patients annually, with more than 900 locations in the U.S. poised to launch the new drug.

“We want to ensure that Aduhelm is affordable for patients and sustainable for health systems,” said one executive.

The company has pledged not to increase the price of the new drug over the next four years. However, executives said they were “open-minded” and suggested reconsidering the price as the company assesses demand over the next few years.

Michel Vounatsos, CEO of Biogen, joined CNBC on Monday and said the drug’s price will allow the company to continue investing in its pipeline of drugs for other diseases. He added that the company works closely with Medicare as well as private insurers.

Categories
Politics

Israeli normal says stopping nuclear program will likely be robust

Iranian Supreme Leader Ayatollah Ali Khamanei speaks during a televised address on March 21, 2021 in Tehran, Iran.

Anadolu Agency | Anadolu Agency | Getty Images

As Iran increases uranium enrichment to 60%, a short jump to 90%, world powers are trying to persuade the Islamic Republic to take a break.

Meetings aimed at returning both Iran and the United States to some form of the 2015 nuclear deal known as the Joint Comprehensive Plan of Action resumed this week in Austria.

While Israel is not part of the talks, it is a major player in the drama that could quickly escalate.

Israel and its Arab allies, including the United Arab Emirates, Bahrain and Saudi Arabia, want the US to increase pressure on Iran by strengthening the JCPOA to address terrorism, missile development and so-called “Iranian expansionism” throughout the Middle East Include east.

Iran and Israel were embroiled in a shadow war that intensified over the past month. An explosion disrupted one of the Iranian nuclear power centers in Natanz. One of the Iranian spy vessels was hit by an explosive device in the Red Sea. and at least two Israeli-owned cargo ships were targeted.

Iran’s decision to increase uranium enrichment came after the explosion in Natanz, which the Islamic Republic of Israel has blamed.

Israel has vowed to destroy Iran’s nuclear program if all else fails, and they have experience in this area.

Forty years ago, in June 1981, eight Israeli F-16s took off, flew over the Red Sea, spanned the Jordan-Saudi border and dropped their bombs on the Iraqi nuclear power plant in Osirak days before it should get hot. It was called Operation Opera and one of the pilots was General Amos Yadlin.

“Saddam and Assad were surprised. Iran has been waiting for this attack for 20 years.”

General Amos Yadlin

Former head of the Israeli military intelligence service

In 2007, Yadlin, as chief of the Israeli army’s military intelligence, helped plan a second operation. This was aimed at Syria’s secret nuclear power plant. Operation Orchard was also a success – the target was completely destroyed.

Yadlin said that if it comes down to it, this time around will be very different: “Saddam and Assad were surprised. Iran has been waiting for this attack for 20 years.”

Yadlin said the Iranian program is “much stronger and more dispersed” while the nuclear programs of Iraq and Syria are concentrated in one place. The Iranian nuclear program is in dozens of places, many of which are buried deep under mountains. In addition, it is not clear whether intelligence agencies know all the details about the locations of the Iranian program.

“Iran learned from what we did, but we also learned from what we did and now we have more skills,” said Yadlin.

Military planners in Israel say that regardless of the Vienna talks, they have five strategies to stop Iran:

  • Option 1: Push for a stronger deal between Iran, the US, Russia, China, France, Germany and the UK.
  • Option 2: Show Iran that the sanctions and diplomacy costs are too high to continue on the current path.
  • Option 3: What is known in Israel as “Strategy C” – with covert attacks, secret actions and cyber attacks. Essentially try anything but war.
  • Option 4: bombing the Iranian nuclear program.
  • Option 5: Push for regime change in Iran. This is the hardest strategy.

Given the strength of the Ayatollahs – their control over the military, the Islamic Revolutionary Guard, and a powerful force known for their brutality – the Basij internal rebellion is a long shot.

Retired Israeli General and Executive Director of the Institute for National Security Studies at Tel Aviv University (INSS) Amos Yadlin attends a meeting of the Security Conference on Manama Dialogue in the Bahraini capital on December 5, 2020.

MAZEN MAHDI | AFP | Getty Images

However, according to Ali Nader, an Iranian analyst with the Foundation for the Defense of Democracies, the regime has become increasingly unpopular domestically, and protests have broken out in the country in recent years. The main reason for these protests is a stalled economy hit hard by US sanctions, which serve as the main US lever against Iran in the Vienna nuclear talks.

“The US has the Iranian economy completely under control,” said Nader. In 2018, Iran had cash reserves worth more than $ 120 billion. Due to sanctions, this inventory fell to around $ 4 billion in 2020, according to estimates by the International Monetary Fund.

The first thing Iran wants during these talks is for the US to relax sanctions and freely sell oil to Asia and Europe. Iran is circumventing sanctions and increasing supplies to China, according to the International Energy Agency, which oversees oil production and deliveries.

Iranian oil shipments to China reached record levels in January. Nader believes that by stopping the US doing more to enforce these sanctions, it is signaling that it is ready to make a deal.

The big question for the talks, however, is who has control over what becomes a chicken game.

Henry Rome is watching the negotiations as an analyst for the Eurasia Group. He doesn’t expect a breakdown or breakthrough as both sides try to get the other to take the first step.

With Iran due to elect a new president in two months’ time, Rome said: “Iran does not want to be viewed as desperate. The Supreme Leader would prefer to wait until after the June 18 elections before even making concessions. ”

“Iran play a weak hand, but they are very good at it,” said Rom.

Yadlin is nervous that the US will be too eager for a deal and give away too much. Repeating what he calls are the mistakes of the 2015 deal. Yadlin points to Iran’s successes in enrichment and reaches the symbolic 60% mark.

“The first deal is proving to be a problem. See how fast they’re moving,” Yadlin said. “You could have enough enriched uranium to get you to two or three bombs quickly.”

While there is still some work to be done in terms of delivery methods and weapons, Yadlin has no doubt that they have the knowledge to make atomic bombs.

Categories
Business

How Texas’ robust winter uncovered U.S. energy grid issues

Texas had a rough winter in 2021.

In mid-February, when temperatures dropped in the single digits, demand for electricity hit a record high across Texas. The supply was running low, causing the state’s utility operator to introduce rolling blackouts. At the height of the crisis, more than 4.5 million customers lost electricity. The unusual winter storm caused neighboring states like Louisiana, Oklahoma, Arkansas, and Kansas to also impose rolling power outages.

Texas residents shivered from the cold as the outages lasted for days. You have lost access to water. Some turned their cars on in their garages to keep warm and then died of carbon monoxide poisoning.

The historic collapse was a wake-up call – if the Texas power grid was so fragile, what about the rest of the United States? According to Climate Central, the US has seen weather-related blackouts have increased by 67% since 2000. Part of the problem is aging infrastructure. Most of today’s power grid was built in the 1950s and 1960s with the hope that it would take 50 years.

Check out the video above to find out what happened in the Texas power outage and how it’s a warning sign on the US power grid.

Categories
World News

U.S.-China commerce relations strained, Biden group retains Trump’s powerful stance

The prospect for US-China trade is likely to continue to be questioned after high-level diplomatic talks this week revealed that President Joe Biden’s team is not planning to use the Trump administration’s harsh tone in talks with Beijing to give up completely.

Although Washington and Beijing signed a ceasefire in their trade feud with last year’s “Phase 1” agreement, representatives on both sides are far from satisfied with the status quo and see the other as major economic rivals.

This competition was seen on Thursday when the countries began two day meetings in Anchorage, Alaska.

Secretary of State Antony Blinken began by stating that the US “would highlight its deep concern about actions by China, including cyber attacks against the United States in Xinjiang, Hong Kong, Taiwan [and] economic constraint on our allies. “

Yang Jiechi, director of the Chinese Communist Party’s Central Foreign Affairs Commission, said the US “does not have the qualifications to say it wants to speak to China from a position of strength”.

Although the talks were viewed as a diplomatic exercise rather than an economic exercise, the prickly exchange is likely an early snapshot of the fierce battles ahead for the Biden trade team. And it is about one of the most valuable trade relationships in the world.

China is currently the US’s third largest merchandise trading partner with a total of $ 558.1 billion (reciprocal trade) in 2019, according to the USTR office. That massive volume of trade supported an estimated 911,000 U.S. jobs as of 2015, with 601,000 from goods exports and 309,000 from service exports.

China is also the third largest export market for American farmers, and annual trade in agricultural commodities totaled $ 14 billion two years ago. China is the largest importer of goods in the United States.

Clete Willems, a former World Trade Organization litigator in the USTR office, told CNBC on Friday that he was not surprised at the lack of progress in Anchorage.

Willems, who was once a member of Trump’s trade team and is now a current partner with the Akin Gump law firm, said the Anchorage meetings were more a chance to officially voice complaints rather than a realistic attempt to take economic remedial action.

“I had low expectations of Alaska and those expectations were met,” said Willems happily of the talks.

“I think [the Chinese government] I misunderstood the situation with the Biden team and they thought these guys would come in and undo all Trump action, “he added.” I think they find out that it won’t. But I think you need to hear it right from blinking. “

The trade negotiations with China are of economic importance, but also provide an opportunity to protect US national security interests and secure access to critical technologies.

Weeks before the meetings in Anchorage, Alaska, the Biden government drafted an executive order directing government departments to review key supply chains, including those for semiconductors, high-capacity batteries, medical supplies, and rare earth metals.

“The Biden administration has signaled that trade at any price is not their position and that they will not curtail their views and neglect human rights or national security (for example) in order to have a ‘good’ trade relationship,” said Dewardric McNeal. An Obama-era political scientist at the Department of Defense said in an email on Friday.

Although Biden’s mandate did not mention China by name, he directed the agencies to investigate gaps in domestic manufacturing and supply chains that are dominated or passed through by “nations that are becoming or becoming unfriendly or unstable.”

The directive has been widely viewed as part of China, one of the world’s largest exporters of rare earth metals, a group of materials used in the manufacture of computer screens, state-of-the-art weapons, and electric vehicles.

US Secretary of State Antony Blinken (2nd R) speaks together with National Security Advisor Jake Sullivan (R) in front of Yang Jiechi (2nd L), director of the office of the Central Commission for Foreign Affairs, and Wang Yi (L), China’s foreigner minister at the US-China talks opening session on March 18, 2021 at the Captain Cook Hotel in Anchorage, Alaska.

Frederic J. Brown | AFP | Getty Images

Still, Chinese negotiators, including Foreign Secretary Wang Yi, may have hoped for a warmer reception from Blinken after four turbulent years under President Donald Trump and his top diplomat Mike Pompeo.

The Trump administration has made it a habit of imposing punitive tariffs and sanctions to counter ongoing complaints about China’s lack of intellectual property protection, required technology transfers, and other unfair business practices.

“The Biden team understands the complexities of trade and commerce between the two countries and hopes to be more focused and predictable in identifying and addressing issues and concerns (more surgical and less destructive), competitive and collaborative,” said McNeal , a senior policy analyst at Longview Global, added on Friday.

As of Friday afternoon, the U.S. team in Alaska had taken no steps to ease restrictions on American sales to Chinese companies, including telecommunications giant Huawei, to ease visa restrictions for members of the Communist Party, or to reopen the Chinese consulate in Houston .

Negotiations with Beijing will likely be a top priority for newly confirmed US sales representative Katherine Tai.

The Senate’s unanimous vote to confirm her nomination, a first for the Biden government, reflects cross-party confidence in her ability as an accomplished and practiced trade attorney.

“Katherine Tai is exactly the kind of qualified and established person who is able to serve President Biden and the country reasonably well,” said Mitch McConnell, chairman of the Senate minority, in the Senate ahead of the confirmatory vote in early March.

Katherine C. Tai speaks ahead of the Senate Finance Committee hearings to consider her appointment as Ambassador of the United States Commercial Agent on February 25, 2021 in Washington, DC.

Bill O’Leary | Pool | Reuters

Tai will soon face a litany of trade disputes instigated by the Trump administration, but talks with Beijing are expected to be a top priority.

She and her team are expected to review Trump’s ongoing policies, including tariffs on Chinese steel, aluminum and consumer goods, as well as components of the Phase 1 deal.

“She knows how to be tough on China and she knows how to do it in coordination with others,” said Willems, who previously represented the US with Tai at the WTO. He added that it will be important for Tai to act as the voice for US trade interests in a government with a deep diplomatic bank.

“You have a government with a very strong secretary of state, very strong national security advisers who are very close to President Biden and who are very oxygen-consuming in US politics in general. And they are going to have to get through that.”

– CNBC’s Nate Rattner and Yen Nee Lee contributed to the coverage.

Categories
Politics

Robust Sanctions, Then a Mysterious Final-Minute Turnabout

WASHINGTON — In early December, an Israeli billionaire named Dan Gertler made an unusual request to the Treasury Department.

A mining magnate who had been accused for years of corruption in deals he struck with leaders of the Democratic Republic of Congo, Mr. Gertler had been slapped with stiff sanctions by the Trump administration in 2017, effectively cutting off his access to the international banking system and freezing money held in U.S. banks.

He had unsuccessfully tried since then to get the sanctions rolled back by hiring high-powered lobbyists and lawyers, including Alan Dershowitz, who had represented President Donald J. Trump in his first impeachment trial, and the former F.B.I. director Louis Freeh.

But with time running out on the Trump administration and the incoming Biden administration unlikely to give his pleas much of a hearing, Mr. Gertler put one last offer on the table: He would agree to have outside monitors track his business and submit regular reports on his financial transactions if the United States would lift the sanctions.

The response came in mid-January, with only days left in Mr. Trump’s term: Treasury Secretary Steven Mnuchin granted Mr. Gertler much of what he wanted, signing off, without any public announcement, on a one-year arrangement that gave him access to money frozen in U.S. banks and allowed him once again to do business with financial institutions worldwide.

The decision stunned and angered American diplomats in Washington and Africa and government officials and human rights activists in the Democratic Republic of Congo, where Mr. Gertler had been accused years earlier by the United Nations and other groups of working with the then-ruling family on deals that looted the nation’s mineral wealth and propped up a corrupt regime.

And it has left the Biden administration scrambling to determine how Mr. Gertler managed to pull it off — and whether it can be reversed.

The episode has echoes of Mr. Trump’s last-minute grants of clemency to political and personal allies and people with connections to him, including the involvement of Mr. Dershowitz. It also highlighted Mr. Gertler’s use of high-powered connections in Israel, including people with ties to Prime Minister Benjamin Netanyahu, and an effort to win support from the U.S. ambassador to Israel.

But the outcome was also distinguished by the secrecy of the process, which cut out the American diplomats most directly responsible for dealing with Congo and fighting corruption in Africa and appeared to have been handled largely at the level of Mr. Mnuchin and Secretary of State Mike Pompeo. The decision became public only after Mr. Trump had left office.

The abrupt reversal of policy toward Mr. Gertler was extraordinary in a number of ways, an investigation by The New York Times found.

Among the findings:

  • The rapid decision to grant Mr. Gertler much of what he wanted defied Treasury Department norms, according to three former agency lawyers, effectively rolling back sanctions with no public documentation justifying the move and without broadly consulting officials at the State Department or the National Security Council. Only last year, some American diplomats and members of Congress in both parties were seeking to expand the sanctions on Mr. Gertler.

  • Mr. Gertler tested the limits of federal law by hiring lawyers who also worked as lobbyists in Washington to push his case, including Mr. Dershowitz, who was instrumental in winning clemency from Mr. Trump for an array of clients, and Mr. Freeh. Treasury rules generally prohibit people under sanctions from spending money on lobbyists in the United States.

  • The Treasury Department’s decision to grant Mr. Gertler a special license was based in part on an assertion that there was a “national security interest” for the United States in Mr. Gertler’s business dealings in Africa, lawyers involved in the effort and Israeli officials said. But some State Department officials were skeptical that his security value could outweigh the human, economic and moral damage contained in the allegations against him. It is also unclear how the balance could have shifted since sanctions were imposed in 2017.

  • Pressure also came from Israel, where Mr. Gertler is represented by prominent lawyers including Boaz Ben Zur, whose client list also includes Mr. Netanyahu. David M. Friedman, then the U.S. ambassador there, was targeted in the push, and then notified Mr. Mnuchin and Mr. Pompeo that he supported the sanctions relief Mr. Gertler wanted, assuming the Treasury Department could work it out.

“I am astounded by this,” said John E. Smith, who served as the director of the Treasury Department’s Office of Foreign Assets Control at the time the sanctions were imposed on Mr. Gertler. “It appears to be an abuse of the process.”

Mr. Mnuchin and Mr. Pompeo, who was also said to be supportive of the decision, both declined to comment.

Mr. Gertler, in a statement, said the decision was not a result of any special influence campaign in Israel or the United States, but instead his promise to be more transparent about his business operations worldwide.

“We will be adopting and implementing the most stringent anti-bribery and anti-corruption policies and measures across all our global practices,” Mr. Gertler said.

But diplomats and human rights activists said they could see no justification for giving a break to Mr. Gertler, who was described by the Treasury Department in 2018 as “engaged in the looting of natural resources and the humanitarian consequences” that followed in poor, strife-torn Congo.

Senior State Department officials in the Trump administration — including Michael Hammer, the U.S. ambassador to Congo; J. Peter Pham, a special envoy; and Tibor P. Nagy, the assistant secretary of state for African affairs — were not informed ahead of time of the move to grant Mr. Gertler the license, contrary to normal practice.

“Here you have one of the most poverty-stricken nations, with a population that has suffered incredibly over the last several decades, and we have worked to turn that around, so why do this?” said Mr. Pham, who until Jan. 20 served as a senior State Department adviser on Africa.

Mr. Gertler arrived in Congo in 1997 as a 23-year-old diamond dealer, determined to challenge the global giant in supplying raw diamonds, the South African-based De Beers.

One of his first big breaks came about three years later, when Laurent Kabila, then the president of Congo, needed weapons to wage a war that would last for more than a decade.

Offering monopolies to foreigners looking to tap into Congo’s rich mineral resources was a way for Mr. Kabila to raise cash needed to fight the war. Among them was a deal to export diamonds with Mr. Gertler, who was considered an appealing intermediary because of his ties to generals in the Israeli Army that could help Congo procure weapons, according to two reports issued by the United Nations in 2001. (Mr. Gertler disputed the findings.)

But the U.N. concluded that Mr. Kabila used money gained selling access to the nation’s mineral wealth — including his deal with Mr. Gertler — to expand the Congolese military forces, a move that helped popularize the terms “conflict diamonds” and “blood diamonds.”

“Conflict diamonds are exchanged for money, weapons and military training,” a U.N. report describing Mr. Gertler’s work said.

Mr. Gertler was also indirectly accused, in a Justice Department court filing in 2016, of paying more than $100 million in bribes to government officials in Congo on behalf of a company named Och-Ziff “to obtain special access to and preferential prices for opportunities in the government-controlled mining sector.”

A spokesman for Mr. Gertler, Aron Shaviv, said Mr. Gertler was never interviewed or charged in the case and he denied any wrongdoing. Instead, Mr. Shaviv said, Mr. Gertler’s companies have directly invested more than $1.5 billion in Congo, becoming one of the nation’s largest employers and taxpayers, starting when no other foreigners were willing to take the risk of doing business in the middle of a war.

“He did buy cheap and he may sell at a much, much higher price because he made the investment when no one else did, no one else would dare go to Congo,” said Mr. Shaviv, a political consultant who served as Mr. Netanyahu’s campaign manager in 2015.

Mr. Gertler first came onto the radar of White House officials in 2002, when Joseph Kabila, who took over the nation after his father was assassinated the prior year, sent a letter to President George W. Bush, looking for help to end the war.

“Please accept my appointed emissary, Mr. Dan Gertler, a respected and well-known international businessman, to speak on my behalf for the needs of the Democratic Republic of Congo,” Mr. Kabila wrote in the April 2002 letter to Mr. Bush, a copy of which was obtained by The New York Times.

“He played a very pivotal role in not only advising Kabila, but also sort of speaking with authority and definitely carrying the United States’ message,” Jendayi E. Frazer, who then served as an adviser to Mr. Bush for African affairs, said in an interview.

Mr. Gertler’s work helped lead to a peace deal in 2003. And it also cemented his relationship with Joseph Kabila. The Congolese government began to grant new deals to Mr. Gertler and his growing empire of companies, which expanded from diamonds into copper, cobalt, oil, gas and gold.

The New Washington

Updated 

Feb. 19, 2021, 7:17 p.m. ET

In just five deals negotiated between 2010 and 2012 to sell copper and cobalt through offshore companies linked to the Fleurette Group, which is controlled by Mr. Gertler and his family, the citizens of Congo lost an estimated $1.36 billion because the nation’s resources were being sold at one-sixth of their value, according to a report prepared in 2013 by Kofi Annan, the former U.N. secretary general, and other prominent African officials.

The forgone revenues to Congo from the deals “were equivalent to more than double the combined annual budget for health and education,” the report concluded.

In Congo, over 70 percent of the population lives in extreme poverty, with an income of less than $1.90 a day. But the profits generated for Mr. Gertler were extraordinary, averaging 512 percent, according to the study, turning him into one of the 29 youngest billionaires in the world, according to Forbes.

It was not just Mr. Gertler who was reported to be becoming tremendously wealthy through these deals.

The corruption and exploitation inherent in these types of deals were just the sort that a new appointee at the Treasury Department named Sigal P. Mandelker was determined to confront when she was confirmed as the top official in charge of sanctions enforcement in 2017.

“Our objective is to change behavior, inspire democracy and freedom, and disrupt the ability of kleptocrats, human rights abusers and others from stealing the wealth of their country,” Ms. Mandelker said in a 2019 speech.

Ms. Mandelker drew bipartisan praise for her effort to take advantage of new authority Congress granted to the Treasury in 2016. The Global Magnitsky Human Rights Accountability Act, as the law is known, is named after a Russian tax lawyer, Sergei Magnitsky, who died in a Moscow prison in 2009 after he exposed corruption by Russian officials.

The new law allowed the Treasury to freeze the assets of individuals or businesses operating anywhere in the world that were engaged in “gross violations of internationally recognized human rights.”

Working with the State and Justice Departments, Ms. Mandelker’s team included Mr. Gertler in the first round of individuals penalized in December 2017, citing his record of “opaque and corrupt” mining and oil deals in Congo. A second round of sanctions in 2018 targeted more companies affiliated with Mr. Gertler.

The sanctions on Mr. Gertler severely constrained his ability to do business around the world by cutting off his access to the United States banking system and limiting his access even to non-U.S. financial institutions concerned about running afoul of the American law.

But less than a year after the sanctions were imposed, Mr. Gertler began his campaign to roll them back.

The push started with a seemingly innocuous request: Grant Mr. Gertler permission to use some of his money to make charitable donations to hospitals, libraries and schools in Congo.

But even that plan drew concern from some State Department officials, who were worried that the donations would allow Mr. Gertler to bolster his standing in Congo and help supporters of Mr. Kabila, by then out of office, challenge efforts by the new, democratically elected president, Félix Tshisekedi, to assert control.

By last year, Mr. Gertler was also battling to rebut a report by two human rights groups citing what they said was evidence that he was evading the sanctions by using a network of shell companies, frontmen and proxy bank accounts to move millions of dollars in and out of Congo and even to acquire new mining rights there.

Mr. Gertler sued both the human rights groups and the Israeli newspaper Haaretz, which published reports detailing the allegations. Lawyers working for Mr. Gertler and a bank in Congo claimed the reports were based on documents that were stolen and then tampered with. The paper and the human rights groups have defended the accuracy of their reporting.

Instead of supporting Mr. Gertler’s bid for permission to make charitable donations, State Department officials responsible for Africa pressed the Treasury Department to expand the sanctions.

But by the end of 2019, key players at the Treasury, including Ms. Mandelker, had started to leave the Trump administration, and State Department officials like Mr. Pham said they found it more difficult to get new Magnitsky sanctions imposed.

The officials turned to the Senate Foreign Relations Committee for help in keeping up the pressure on Mr. Gertler. In August, members of the committee sent the Treasury Department a bipartisan letter that did not mention him by name but carried a clear message.

To help build democracy and fight corruption in Congo, the letter said, the United States “should designate additional officials and companies responsible for or complicit in high-level corruption, including the misappropriation of state assets, for targeted financial and travel sanctions.”

But Mr. Gertler’s team, including Mr. Dershowitz and Mr. Freeh, had a different message. They had solicited a letter from Ms. Frazer attesting to Mr. Gertler’s role in the peace negotiations nearly two decades earlier and distributed it to Trump administration officials. As far back as 2019, they set up meetings with State Department officials, making the case that his activities had helped the interests of the United States.

“His first effort was a lobbying effort,” Mr. Shaviv said of Mr. Gertler’s campaign.

But Treasury rules state that “professional services such as lobbying, public relations, government affairs, consulting and business development are not legal services, and are generally not covered” by an exemption that allows people under sanctions to hire lawyers.

Mr. Dershowitz said the meetings were permitted because he did not lobby the White House or others on this matter.

“My role was purely limited to the legal issues,” Mr. Dershowitz said.

But with time running out on Mr. Trump’s tenure and the sanctions still not lifted, Mr. Gertler decided to make a strategy shift. While not admitting any past wrongdoing, Mr. Gertler’s lawyers told the Treasury Department in early December that he was prepared to take any reasonable steps to assure the United States that he would abide by the law, including hiring outside monitors and submitting detailed periodic reports on financial transactions.

“Our entire approach was to assure them that going forward, there would be no problem,” Mr. Shaviv said.

At the same time, assertions were being made that Mr. Gertler had been of value to U.S. intelligence agencies.

“It’s absolutely the case that the national security interests of both Israel and the United States were implicated in this,” Mr. Dershowitz said, although he and others declined to provide any specifics. Mr. Shaviv declined to discuss whether Mr. Gertler had undertaken any such activities, but said that if they did take place, they would be described as “services rendered to the United States of America.”

Whatever Mr. Gertler did that benefited the United States was sensitive enough that Israeli officials said they were aware of it but declined to comment on its nature. Two Israeli officials told The Times that the United States had informed Israel that in line with a decision by Mr. Mnuchin and Mr. Pompeo, the terms of the sanctions imposed on Mr. Gertler would be eased “out of reasons of American national security.”

But several former State and Treasury Department officials said that while as a foreigner operating in Congo Mr. Gertler might have had information the United States considered valuable, keeping him on the sanctions list also had a value to Washington by helping to promote the anti-corruption effort.

“The only value to national security that Gertler has comes from him being placed in the box that he was put into with the sanctions,” Mr. Pham said.

In any case, the decision to grant him the one-year license was unusual in a number of respects, they said.

The Treasury Department traditionally agrees to revoke sanctions only after individuals have proved they have already changed their behavior, not simply agreed to make such changes in the future, said Mr. Smith, the former head of the sanctions unit, who is now a national security lawyer at the law firm Morrison and Foerster. Mr. Gertler had not previously provided the United States such evidence.

Furthermore, if Mr. Gertler’s assets in U.S. banks were going to be unfrozen and his corporate entitles allowed to once again do business with United States financial institutions, as the license allowed, that kind of deal would almost certainly need to be made public, not issued in secret as this one was. This kind of review also typically takes months of effort, not the six weeks that it took in this case.

“This is a unique, one-of-a-kind response that you don’t see with the United States government,” Mr. Smith said of the so-called specific license that Mr. Gertler received. “It is the most shocking license I have ever seen in a few decades of working on economic sanctions.”

When word of the decision to grant Mr. Gertler the one-year license eventually trickled out after Mr. Trump left office, it set off a firestorm of criticism from officials who said it would undercut efforts by the United States to fight corruption.

Mr. Hammer, the U.S. ambassador to Congo, was at first ​so ​confused at the news, according to one State Department official briefed on the matter, ​​​that he​ called officials in Washington to figure out if ​a ​mistake had been made.

“This has made my job much tougher​​,” an angry Mr. Hammer told colleagues.​​​

House and Senate Democrats fired off letters to the Treasury and State Departments. A coalition of 30 Congolese and international human rights groups assailed the move, with one of the letters calling the move a “terrible blow to the heart of one of the most lauded and effective anti-corruption programs of the last decade.”

The Biden administration is now investigating why the license was issued, and if it could be revoked, although Mr. Gertler’s team said that it would have no justification to take such a step.

Mr. Gertler, meanwhile, has begun a campaign to rehabilitate his image in Congo, releasing promotional videos detailing his work to support local hospitals and schools there and calling the citizens of Congo “brothers and sisters.” He also started a plan to allow residents of Congo to invest in one of his new mining projects.

Activists in Congo were not impressed.

“How can someone who has done so much harm to Congo for 20 years suddenly say he’s an angel?” said Jimmy Kande, a leader in the nonprofit group Congo Is Not for Sale. “If Congolese authorities would finally look at Gertler’s past, he shouldn’t have much of a future in Congo.”

Kenneth P. Vogel, Lara Jakes and Julian E. Barnes contributed reporting.

Categories
Health

Covid kills somebody about each 15 minutes in LA County, forcing hospitals to make ‘powerful choices’

An ambulance crew waits with a patient outside the Coast Plaza Hospital emergency room during a surge in coronavirus disease (COVID-19) cases in Los Angeles, California on December 26, 2020.

David Swanson | Reuters

The Covid-19 outbreak is so severe in Los Angeles County that ambulances have to wait hours to drop patients off to emergency rooms.

Hospital beds are cluttered in souvenir shops, cafeterias, and conference rooms as hospitals struggle to find space for patients.

The Los Angeles County Emergency Services Department on Monday urged EMS workers to only administer supplemental oxygen when a patient’s saturation level drops below 90% in order to reduce oxygenation. Paramedics have also been advised not to transport adult heart attack patients to hospital unless they can restore “spontaneous circulation” in the field – to focus care on patients who are more likely to survive.

Los Angeles is facing an unprecedented surge in coronavirus patients that is marginalizing hospitals in the area. Public health officials warn that the already dire situation is likely to worsen in January.

“Many hospitals have reached a crisis point and are facing very difficult decisions about patient care,” said Dr. Christina Ghaly, the district’s health manager, at a press conference on Monday. She urged residents to avoid the emergency room unless they need serious medical attention.

Hospitals have reached their limits since Decemer, when the region’s intensive care unit capacity quickly dropped to zero, according to state health officials. More than 8,000 people have now been hospitalized with the virus in the county, and 20% of those people are in intensive care units, data from the county health department shows. With the virus so prevalent, public health officials warn that conditions are likely to get worse before they improve.

Paramedics (EMTs) and health care workers treat patients outside the Huntington Park Community Hospital emergency room during a surge in positive coronavirus disease (COVID-19) cases in Huntington Park, California, December 29, 2020.

Bing Guan | Reuters

Across California, approximately 370 people die from Covid-19 every day based on a weekly average – a nearly 46% increase compared to a week ago. This comes from a CNBC analysis of the data compiled by Johns Hopkins University.

In Los Angeles County, the coronavirus kills someone every 15 minutes on average, the county’s public health director Barbara Ferrer said during Monday’s briefing. The county exceeded a total of 11,000 deaths from Covid-19 on Tuesday, 1,000 of which occurred in less than a week, the health department said in a statement.

Everyone in the area should assume they will be exposed to the disease if they leave their home, Ferrer said. One in five people tested for Covid-19 in Los Angeles County has the virus.

“We’re likely to see the worst of conditions in January facing the entire pandemic, and that’s hard to imagine,” Ferrer said. “The rise in cases is likely to continue for weeks due to holiday and New Year’s parties and returning travelers.”

The staff was stretched thin

Los Angeles County is still grappling with the Covid-19 spate that was sparked by the Thanksgiving holiday and has yet to see the cases that are likely to follow the holidays in late December, Ghaly said. Hospitals are now trying to “do everything they can to prepare”.

Some coronavirus patients have to wait more than a day for a bed to be opened for them in the intensive care unit, shared Dr. Brad Spellberg, chief medical officer of the Los Angeles County University Medical Center’s Southern California Medical Center, emailed CNBC.

A health care worker examines patients in an oxygen tent outside the emergency room of Huntington Park Community Hospital during a surge in positive coronavirus (COVID-19) cases in Huntington Park, California, December 29, 2020.

Bing Guan | Reuters

The hospital had to recruit some of its health care workers to handle the influx of ICU patients, meaning there is no time for elective surgery or other life-saving procedures like colonoscopies, Spellberg said.

Governor Gavin Newsom said during a news conference Monday that the state had sent medical aid teams to the Los Angeles area to ease the burden on hospitals. However, if there is another spike in Covid-19 cases after the December break, the extra staff won’t be enough, Spellberg said.

“Our staff are still very thin, especially in the intensive care unit. You can’t just get more nurses and doctors in the intensive care unit,” Spellberg said in an email, urging people to continue following public health guidelines such as wearing of masks, physical distancing and avoiding the crowds to follow.

“We get knocked down”

The increase is due to the fact that California, along with other states in the United States, began to administer the first shots of Covid-19 vaccines from Pfizer and Moderna.

The state has received just over 2 million doses of vaccines, but only 24% of those have been given, according to the state’s Department of Health’s database last updated Wednesday. Newsom said Monday the process is too slow and the state “wants to see things go much faster”.

Ravina Kullar, a Los Angeles-based infectious disease expert and a member of the Infectious Diseases Society of America, told CNBC in a telephone interview that she expects vaccinations to speed up in the coming weeks, even though the shots won’t work immediately. Immunity takes a few weeks to build and too few are given to develop herd immunity that would protect the wider population.

“I think we’re going to see some sort of stability that plateau and decrease in some cases, but it will only take time,” said Kullar. “I think it will be until spring, summer, before something really becomes noticeable there.”

Kullar, who works in long-term care facilities and nursing homes in Los Angeles, said every facility she works with is battling a Covid-19 outbreak. These residents, along with health care workers, will be the first to receive vaccination shots in California when they are introduced, Newsom said, adding that there are approximately 3 million people in the state’s early stages of vaccination.

“We’re getting down,” said Kullar. “We have very few staff. I am exhausted, my colleagues are exhausted. It’s a very difficult situation out here.”

– The Associated Press contributed to this report.